Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1

1d ago, source:

Daré Bioscience’s DARE-LARC1 Platform Technology has Transformative Potential for Women’s Health as well as in Treating a ...

Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2023 Earnings Call Transcript

23d ago, source: InvestingChannel on MSN

Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2023 Earnings Call Transcript March 28, 2024 Daré Bioscience, Inc. beats earnings ...

Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update

28d ago, source: Business Insider

Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the year ended December 31, 2023 and provided a company update. “We are ...

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.12%

on MSN ago, source:

U.S. stocks were lower after the close on Wednesday, as losses in the Technology, Industrials and Consumer Services sectors ...

Q4 2023 Dare Bioscience Inc Earnings Call

27d ago, source: Yahoo Finance

Sabrina Martucci Johnson; President and CEO; Dare Bioscience, Inc. MarDee Haring-Layton; Chief Accounting Officer; Dare Bioscience, Inc. Douglas Tsao; Analyst; H.C ...

Dare Bioscience Inc

10d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update

27d ago, source: Stockhouse

Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the year ended December 31, 2023 and provided a company update. “We ...

Daré Bioscience, Inc. (DARE) Q4 2023 Earnings Call Transcript

27d ago, source: Seeking Alpha

Welcome to the conference call hosted by Daré Bioscience to review the company’s Fourth Quarter Financial Results and to provide a General Business Update. This call is being recorded.

Daré Bioscience, Inc.: Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update

27d ago, source: Finanznachrichten

Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today reported financial results for the year ended December 31, 2023 and provided a company update. "We are pleased ...

Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2023 Earnings Call Transcript

23d ago, source: Insider Monkey

Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.12. DARE isn’t one of the 30 most popular stocks among hedge funds at the end of the third ...